Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program-Reference-Cited by-同舟云学术

Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program

Published:2014-10-29 Issue:12 Volume:12 Page:2024-2033
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Michal M.¹²,Prochaska J. H.³⁴,Ullmann A.³,Keller K.³⁴,Gobel S.³,Coldewey M.³⁴,Münzel T.²³⁴,Wiltink J.¹,Beutel M. E.¹,Wild P. S.²⁵

Affiliation:

1. Department of Psychosomatic Medicine and Psychotherapy; University Medical Center of the Johannes Gutenberg-University Mainz; Mainz Germany

2. German Center for Cardiovascular Research (DZHK); Partner Site Rhine-Main; Mainz Germany

3. Center for Thrombosis and Hemostasis; University Medical Center Mainz; Johannes Gutenberg University Mainz; Mainz Germany

4. Department of Medicine II; University Medical Center of the Johannes Gutenberg-University Mainz; Mainz Germany

5. Preventive Cardiology and Preventive Medicine; Department of Medicine II, University Medical Center of the Johannes Gutenberg-University Mainz; Mainz Germany

Funder

Ministries of health and economy, Rhineland-Palatinate Germany

Federal Ministry of Education and Research

Boehringer Ingelheim Pharma GmbH & Co. KG

Bayer Vital GmbH

Daiichi Sankyo Europe GmbH

Sanofi-Aventis Germany GmbH

IMO Institut GmbH and Portavita BV

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12743/fullpdf

Reference45 articles.

1. Evaluation of oral anticoagulation therapy: rationale and design of the thrombEVAL study programme;Prochaska;Eur J Prev Cardiol,2014

2. A method to determine the optimal intensity of oral anticoagulant therapy;Rosendaal;Thromb Haemost,1993

3. Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics;Cruess;Int J Behav Med.,2010

4. Risk factors for nonadherence to warfarin: results from the IN RANGE study;Platt;Pharmacoepidemiol Drug Saf,2008

5. CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study;Caraco;Clin Pharmacol Ther,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Description of self-care behaviours in patients with non-valvular atrial fibrillation on oral anticoagulant therapy: a scoping review;European Journal of Cardiovascular Nursing;2024-01-24

2. MECHANICAL MITRAL VALVE THROMBOSIS AND CARDIOGENIC SHOCK FROM INTERRUPTED ANTICOAGULATION DUE TO SEVERE DEPRESSION;CHEST;2023-10

3. Atherosclerosis and Its Impact on the Outcomes of Patients with Deep Venous Thrombosis;Life;2022-05-14

4. Atrial Fibrillation and Depression: A Bibliometric Analysis From 2001 to 2021;Frontiers in Cardiovascular Medicine;2022-02-16

5. Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation;The American Journal of Cardiology;2021-08